Lifevantage EPS - Earnings per Share 2010-2023 | LFVN

Lifevantage eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Lifevantage Annual EPS
2023 $0.20
2022 $0.24
2021 $0.90
2020 $0.79
2019 $0.50
2018 $0.41
2017 $0.11
2016 $0.42
2015 $0.50
2014 $0.71
2013 $0.42
2012 $0.77
2011 $-4.83
2010 $-1.33
2009 $-1.61
Lifevantage Quarterly EPS
2023-12-31 $-0.05
2023-09-30 $0.05
2023-06-30 $0.15
2023-03-31 $0.08
2022-12-31 $-0.08
2022-09-30 $0.05
2022-06-30 $-0.11
2022-03-31 $0.09
2021-12-31 $0.01
2021-09-30 $0.25
2021-06-30 $0.35
2021-03-31 $0.12
2020-12-31 $0.26
2020-09-30 $0.17
2020-06-30 $0.26
2020-03-31 $0.11
2019-12-31 $0.30
2019-09-30 $0.12
2019-06-30 $0.26
2019-03-31 $0.12
2018-12-31 $0.06
2018-09-30 $0.06
2018-06-30 $0.21
2018-03-31 $0.12
2017-12-31 $0.02
2017-09-30 $0.06
2017-06-30 $0.01
2017-03-31 $0.00
2016-12-31 $0.02
2016-09-30 $0.08
2016-06-30 $0.16
2016-03-31 $0.07
2015-12-31 $0.11
2015-09-30 $0.08
2015-06-30 $0.04
2015-03-31 $0.04
2014-12-31 $0.10
2014-09-30 $0.32
2014-06-30 $0.15
2014-03-31 $0.14
2013-12-31 $0.21
2013-09-30 $0.21
2013-06-30 $0.00
2013-03-31 $0.21
2012-12-31 $0.00
2012-09-30 $0.21
2012-06-30 $0.63
2012-03-31 $-0.35
2011-12-31 $0.35
2011-09-30 $0.14
2011-06-30 $-3.92
2011-03-31 $-0.91
2010-12-31 $0.42
2010-09-30 $0.07
2010-06-30 $-0.56
2010-03-31 $-0.98
2009-12-31 $-0.07
2009-09-30 $0.14
2009-06-30 $-0.77
2009-03-31 $-0.84
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.085B $0.213B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.110B 18.50
Becton Dickinson (BDX) United States $67.086B 19.48
West Pharmaceutical Services (WST) United States $27.625B 46.70
Cardinal Health (CAH) United States $25.909B 15.57
Align Technology (ALGN) United States $22.586B 45.54
Cooper (COO) United States $17.860B 27.03
Labcorp (LH) United States $16.823B 14.37
Henry Schein (HSIC) United States $9.019B 15.60
DENTSPLY SIRONA (XRAY) United States $6.296B 16.59
Merit Medical Systems (MMSI) United States $4.152B 23.76
Patterson (PDCO) United States $2.305B 11.04
STAAR Surgical (STAA) United States $2.264B 71.29
CONMED (CNMD) United States $2.240B 21.09
Atrion (ATRI) United States $0.702B 36.15
Pro-Dex (PDEX) United States $0.064B 24.35
Biolase (BIOL) United States $0.005B 0.00